Inventage Lab (XKRX:389470) Cash And Cash Equivalents : ₩0.0 Mil (As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Inventage Lab Cash And Cash Equivalents?

Inventage Lab's quarterly cash and cash equivalents declined from Sep. 2023 (₩18,558.93 Mil) to Dec. 2023 (₩18,481.91 Mil) but then stayed the same from Dec. 2023 (₩18,481.91 Mil) to Mar. 2024 (₩0.00 Mil).

Inventage Lab's annual cash and cash equivalents declined from Dec. 2021 (₩19,256.13 Mil) to Dec. 2022 (₩15,780.96 Mil) but then increased from Dec. 2022 (₩15,780.96 Mil) to Dec. 2023 (₩18,481.91 Mil).

Inventage Lab Cash And Cash Equivalents Historical Data

The historical data trend for Inventage Lab's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Inventage Lab Cash And Cash Equivalents Chart

Inventage Lab Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Cash And Cash Equivalents

3,928.00

11,930.19

19,256.13

15,780.96

18,481.91

Inventage Lab Quarterly Data
	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Cash And Cash Equivalents	Get a 7-Day Free Trial					11,262.61	25,077.23	18,558.93	18,481.91	-

Inventage Lab Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Inventage Lab (XKRX:389470) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.

Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.

Inventage Lab Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of Inventage Lab's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.

Inventage Lab (XKRX:389470) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Inventage Lab Inc (XKRX:389470) » Definitions » Cash And Cash Equivalents

Traded in Other Exchanges

N/A

Address

24, Dunchon-daero 388 beon-gil, 612, Woolim Lions Valley 3, Jungwon-gu, Gyeonggi-do, Seongnam-si, KOR, 13403

Website

https://www.inventagelab.com

Inventage Lab Inc operates medical technology development businesses. It engages in the development of an innovative Drug Delivery System (DDS). It has developed Laminar FluiDigm, a microfluidics-based novel platform technology that builds the foundation for IVL- DrugFluidic and IVL-GeneFluidic, which are specific platform technologies used for developing and manufacturing long-acting injectables and gene-delivery therapeutics.

Inventage Lab (XKRX:389470) Headlines

No Headlines